NI

Nextech Invest Portfolio holdings

AUM $528M
This Quarter Return
-5.76%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$251M
AUM Growth
+$251M
Cap. Flow
-$2.03M
Cap. Flow %
-0.81%
Top 10 Hldgs %
94.15%
Holding
14
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$2.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$7.1B
$99.8M 39.7% 4,189,529 – –
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$32.2M 12.82% 13,104,424 – –
TYRA icon
3
Tyra Biosciences
TYRA
$675M
$19.1M 7.62% 2,518,582 – –
SPRY icon
4
ARS Pharmaceuticals
SPRY
$1.15B
$16.3M 6.48% 1,910,029 – –
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$14.2M 5.65% 2,329,480 -332,408 -12% -$2.03M
CGEM icon
6
Cullinan Oncology
CGEM
$445M
$12.9M 5.13% 1,221,145 – –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$74.2M
$12.1M 4.8% 1,385,807 – –
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$12M 4.76% 263,914 – –
ARVN icon
9
Arvinas
ARVN
$568M
$9.83M 3.91% 287,251 – –
BPMC
10
DELISTED
Blueprint Medicines
BPMC
$8.25M 3.28% 188,228 – –
RLAY icon
11
Relay Therapeutics
RLAY
$619M
$7.1M 2.83% 475,485 – –
THRX
12
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.04M 1.21% 611,310 – –
KRON
13
DELISTED
Kronos Bio
KRON
$2.35M 0.94% 1,451,537 – –
CCCC icon
14
C4 Therapeutics
CCCC
$185M
$2.22M 0.88% 375,857 – –